Product Description
D-(+)-Galactosamine Hydrochloride
Application Notes
D-(+)-Galactosamine (D-chondrosamine) is used with lipopolysaccharides (LPS) to induce models of acute hepatic failure (LPS/D-GalN-induced liver injury, hepatitis) for therapeutic research to find new drugs.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Inhibitor of hepatic RNA synthesis
Specifications
SKU | 02101743-CF |
Alternate Names | Chondrosamine hydrochloride; 2-Amino-2-deoxy-D-galactopyranose hydrochloride; D-Chondrosamine hydrochloride; D-Chondrosamine HCI |
Application Notes | D-(+)-Galactosamine (D-chondrosamine) is used with lipopolysaccharides (LPS) to induce models of acute hepatic failure (LPS/D-GalN-induced liver injury, hepatitis) for therapeutic research to find new drugs. |
Base Catalog Number | 101743 |
Beilstein Registry Number | 3697825 |
Biochemical Physiological Actions | Increases the adherence of polymorphonuclear leukocytes to hepatic endothelial cells and induces superoxide production. Induces hepatic damage, causing macrophage infiltration. |
CAS # | 1772-03-8 |
EC Number | 217-198-1 |
Format | Powder |
Molecular Formula | C6H13NO5·HCl |
Optical Rotation | + 93 ± 5°(c=1, water, after 24 hrs.) |
Personal Protective Equipment | Eyeshields, Gloves, respirator filter |
Purity | ≥99% |
RTECS Number | LW5500000 |
Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
Documents
Certificate of Analysis (COA)
Datasheet
Datasheet
Safety Data Sheets
English (United States)
Citations